Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Augmenter of liver regeneration | 0.0036 | 0.0839 | 0.0787 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.3061 | 0.2818 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0094 | 0.3061 | 0.3022 |
Echinococcus granulosus | FAD linked sulfhydryl oxidase ALR | 0.0036 | 0.0839 | 0.2741 |
Brugia malayi | 4-aminobutyrate aminotransferase, mitochondrial precursor | 0.0022 | 0.0339 | 0.0284 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0094 | 0.3061 | 0.3061 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0455 | 0.2327 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0056 | 0.0056 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.0158 | 0.5478 | 0.532 |
Echinococcus multilocularis | lamin | 0.0028 | 0.055 | 0.1796 |
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.055 | 0.1796 |
Echinococcus granulosus | Aminotransferase class III | 0.0022 | 0.0339 | 0.1107 |
Brugia malayi | MH2 domain containing protein | 0.0127 | 0.4295 | 0.4263 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0094 | 0.3061 | 1 |
Mycobacterium ulcerans | glutaminase | 0.0277 | 1 | 1 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0036 | 0.0839 | 1 |
Toxoplasma gondii | Erv1 / Alr family protein | 0.0036 | 0.0839 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.055 | 0.0496 |
Echinococcus granulosus | lamin | 0.0028 | 0.055 | 0.1796 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.0158 | 0.5478 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.055 | 0.055 |
Echinococcus multilocularis | musashi | 0.0028 | 0.055 | 0.1796 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.3061 | 0.2818 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.055 | 0.055 |
Trypanosoma brucei | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0036 | 0.0839 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0127 | 0.4295 | 0.4295 |
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.055 | 0.1796 |
Echinococcus multilocularis | FAD linked sulfhydryl oxidase ALR | 0.0036 | 0.0839 | 0.2741 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.053 | 0.053 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.0022 | 0.0339 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.3061 | 0.2818 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.0455 | 0.2327 |
Schistosoma mansoni | lamin | 0.0028 | 0.055 | 0.0218 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0022 | 0.0339 | 0.1107 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.0455 | 0.2327 |
Mycobacterium leprae | PROBABLE ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE BIOA | 0.0158 | 0.5478 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.0277 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0455 | 0.2327 |
Echinococcus multilocularis | Aminotransferase class III | 0.0022 | 0.0339 | 0.1107 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0094 | 0.3061 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.055 | 0.055 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0455 | 0.0455 |
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.055 | 0.1796 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0094 | 0.3061 | 1 |
Onchocerca volvulus | 0.0028 | 0.055 | 0.5 | |
Schistosoma mansoni | lamin | 0.0028 | 0.055 | 0.0218 |
Schistosoma mansoni | glutaminase | 0.0277 | 1 | 1 |
Loa Loa (eye worm) | hepatopoietin HPO2 | 0.0036 | 0.0839 | 0.0839 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0036 | 0.0839 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0277 | 1 | 1 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0022 | 0.0339 | 0.1107 |
Schistosoma mansoni | intermediate filament proteins | 0.0028 | 0.055 | 0.0218 |
Loa Loa (eye worm) | glutaminase | 0.0277 | 1 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0127 | 0.4295 | 0.4295 |
Plasmodium falciparum | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0036 | 0.0839 | 1 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.055 | 0.0496 |
Plasmodium vivax | FAD-linked sulfhydryl oxidase ERV1, putative | 0.0036 | 0.0839 | 1 |
Trypanosoma cruzi | ERV/ALR sulfhydryl oxidase domain-containing protein | 0.0036 | 0.0839 | 1 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.0158 | 0.5478 | 1 |
Onchocerca volvulus | 0.0028 | 0.055 | 0.5 | |
Wolbachia endosymbiont of Brugia malayi | acetylornithine transaminase protein | 0.0022 | 0.0339 | 0.5 |
Echinococcus granulosus | ornithine aminotransferase | 0.0022 | 0.0339 | 0.1107 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0112 | 0.0056 |
Leishmania major | hypothetical protein, conserved | 0.0036 | 0.0839 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0158 | 0.5478 | 0.532 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 4 | 0.0036 | 0.0839 | 1 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0455 | 0.0401 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0094 | 0.3061 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.